arrow
Back
O

Olivier Bouché

CHU Reims and Université Reims Champagne-Ardenne

83H-index
759Paper Count
4.2WCitation Count
Published Papers 222
Publication Date
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis☆
err2026-06-10
err0
errOAAI
errA. Raimondi; G. Tinè; V. Boige; A. De Stefano; A. Ballhausen; S. Gourgou; F. Giuliani; A. Stahler; G. Randon; M. Prisciandaro; P. Manca; M. Ambrosini; R. Fazio; S. Mohamed; G. Gronchi; G. Santabarbara; E. Brument; A.H.S. Alig; R. Miceli; O. Bouche
errShare
errSave
Dihydropyrimidine dehydrogenase phenotype-guided dose individualization of fluoropyrimidine in gastrointestinal cancers: PRODIGE100-UCGI48-FUDOSE phase II study
err2026-05-22
err0
errOAAI
errG.M. Camilleri; M.A. Loriot; G. Le Teuff; F. Thuillier; O. Bouche; C. Narjoz; M. Ben Abdelghani; C. Herve; S. Corbinais; C. Locher; T. Lecomte; M. Villemin; D. Tougeron; C. Lepage; A. Peytier; AS Moussaddaq; O. Dubreuil; M. Mabro; J. Desrame; N. De Sousa Carvalho
errShare
errSave
Gastric cancer: French Intergroup clinical practice guidelines for diagnosis, staging, treatment and follow-up (TNCD, SNFGE, FFCD, UNICANCER, GERCOR, SFCD, SFED, AFEF, SFRO, SFP, SFR, ACHBPT, RENAPE, SNFCP)
err2026-03-24
err0
errOAAI
errAziz Zaanan; Juliette Palle; Florence Renaud; Maximilien Barret; Meher Ben abdelghani; Bruno Buecher; Nicolas Chapelle; Olivier Dubreuil; Jerome Durand-Labrunie; Nadim Fares; Johan Gagniere; Marine Jary; Antoine Mariani; Lola-Jade Palmieri; Michel Ducreux; Olivier Bouché
errShare
errSave
Clinical and Economic Outcomes of Adding Durvalumab to Gemcitabine/Cisplatin in Advanced Biliary Tract Cancers: A Multicenter Descriptive Study
err2025-11-19
err0
errOAAI
errLena Luciani; Claire Carlier; Léonie Leuk; Justine Clarenne; Violaine Lepage; Marine Perrier; Olivier Bouché; Elia Gigante; Florian Slimano
errShare
errSave
Association between induced organ atrophy assessed by artificial intelligence-generated automatic segmentation and efficacy of bevacizumab in combination with chemotherapy in metastatic colorectal cancer
err2025-11-18
err0
errOAAI
errMalik Laich; Mathias Brugel; Pierre Henri Conze; Marwan Abbas; Mohammed Ben Abdelghanie; Faiza Khemissa; Sylvie Kircher; Karine Le Malicot; Côme Lepage; Thomas Aparicio; Christine Hoeffel; Olivier Bouché; Claire Carlier
errShare
errSave
Methodological approach to optimize a step-by-step deterministic linkage of SNDS data with a clinical database (FREGAT) of gastric/gastroesophageal junction adenocarcinoma in France: Pitfalls and learnings
err2025-11-07
err0
PREAI
errLaborey, Magali; Lajoinie, Audrey; Freilich, Jonatan; Samalin, Emmanuelle; Bouche, Olivier; Piessen, Guillaume; Stoelzel, Matthias; Chilelli, Andrew
errShare
errSave
Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial
err2025-11-04
err0
errOAAI
errStefano Kim; Jihane Boustani; Soledad Iseas; Dewi Vernerey; Ludovic Evesque; Laurent Quero; Francois Ghiringhelli; Clélia Coutzac; Olivier Bouché; Benoist Chibaudel; Chloé Vernet; Angélique Vienot; David Tougeron; Thierry Nguyen; Magali Rebucci-Peixoto; Aurélia Meurisse; Sarah Chennoufi; Christophe Maritaz; Christophe Borg
errShare
errSave
Palliative Care Referral Practices and Impact on Survival of Patients Diagnosed With Advanced Hepatocellular Carcinoma
err2025-10-17
err0
PREAI
errAntoine Dupuis; Alix Demory; Elia Gigante; Mohamed Bouattour; Claire Carlier; Jean-Charles Nault; Marine Perrier; Florian Slimano; Vincent Sanchez; Kamélia Smati; Olivier Bouché; Mathias Brugel
errShare
errSave
Circulating tumor DNA driving anti-EGFR rechallenge therapy in metastatic colorectal cancer: the RASINTRO prospective multicenter study
err2025-09-01
err0
PREAI
errZaanan, Aziz; Bergen, Elisabeth Sophie; Evesque, Ludovic; Meurisse, Aurelia; Artru, Pascal; Lecomte, Thierry; Bouche, Olivier; Lepere, Celine; Ambrosini, Margherita; Coriat, Romain; Lievre, Astrid; Cohen, Romain; Boige, Valerie; Louafi, Samy; Bachet, Jean-Baptiste; Goyer, Sophie; Taieb, Julien; Vernerey, Dewi; Blons, Helene; Laurent-Puig, Pierre
errShare
errSave
Deep learning on histological slides accurately predicts Consensus Molecular Subtypes and spatial heterogeneity in colon cancer
err2025-08-25
err0
PREAI
errJean-Eudes LE DOUGET; Paul JACOB; Côme LEPAGE; Claire GALLOIS; Marine SROUSSI; Aurélien D.E. REYNIES; Antoine CAZELLES; Daniel GONZALEZ; Charles MAUSSION; Olivier BOUCHE; Charles-Briac LEVACHE; Marine JARY; Laurent MINEUR; Simon JEGOU; Charlie SAILLARD; Mehdi MOREL; Julien TAÏEB; Frédéric BIBEAU; Jean-François EMILE; Pierre LAURENT-PUIG
errShare
errSave
Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (PRODIGE 62-FFCD 1701-OESIRI)
err2025-08-22
err0
errOAAI
errDavid Tougeron; Laurent Mineur; Aziz Zaanan; Melissa Kadi; Catherine Poisson Ligeza; Vincent Bourgeois; Jérôme Martin-Babau; Aurélie Fadin; Véronique Jestin le Tallec; Valérie Ly Lebrun; Olivier Dubreuil; Faiza Khemissa Akouz; Elsa Thimonier; Olivier Bouché; Astrid Lièvre; Frédéric Di Fiore; Thierry Lecomte; Côme Lepage; Vincent Hautefeuille
errShare
errSave
Hepatic Metastases Management: A Comparative Review of Surgical Resection, Thermal Ablation, and Stereotactic Body Radiation Therapy.
err2025-08-05
err0
PREAI
errPaolo Torielli; Jeremy McGale; Matthew J. Liao; Rami Rhaiem; Olivier Bouche; Damien Botsen; Olivier Gerin; Abdallah Lamane; Yaacov Lawrence; George Madelis; Laura Rozenblum; Abin Sajan; Mickael Tordjman; Laurent Dercle; Arnaud Beddok
errShare
errSave
Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients – A post-hoc analysis of the PETACC 8 trial
err2025-07-12
err0
errOAAI
errElisabeth Sophie Bergen; Clémence Canton; Mathieu Boulin; Karine Le Malicot; Jaafar Bennouna; Daniel Gonzalez; Laurent Mineur; Olivier Bouche; Côme Lepage; Julien Taieb
errShare
errSave
Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial)
err2025-05-01
err0
errOAAI
errLecomtea, Thierry; Giraudeauc, Bruno; Phelipd, Jean-Marc; Tournigande, Christophe; Ducreuxf, Michel; Tougerong, David; Lepageh, Come; Mineuri, Laurent; Laplaigej, Philippe; Desgrippesk, Romain; Artrul, Pascal; Borgm, Christophe; Jaryn, Marine; Boucheo, Olivier; Metges, Jean-Philippe; Guimbaud, Rosine; Aparicio, Thomas; Foubert, Fanny; Hautefeuillet, Vincent; Muller, Marie; Bouhier-Leporrierv, Karine; Darriusw, Remi; Lobetb, Sarah; Monmousseaux, Fanny; Bejan-Angoulvanty, Theodora; Paintaud, Gilles; Ternant, David
errShare
errSave
Regorafenib combined with irinotecan as second-line treatment in metastatic gastro-oesophageal adenocarcinomas: results of PRODIGE 58-UCGI35-REGIRI Unicancer randomised phase II study
err2025-05-01
err0
errOAAI
errSamalin, E.; Evesque, L.; Turpin, A.; de la Fouchardiere, C.; Khemissa-Akouz, F.; Bouche, O.; Muller, M.; Dermeche, S.; Botsen, D.; Tougeron, D.; Zaanan, A.; Ben Abdelghani, M.; Guardiola, E.; Dubreuil, O.; Ly, V. Le Brun; Hennequin, A.; Watson, S.; Sefrioui, D.; Lecomte, T.; Carvalho, N. De Sousa; Hulin, A.; Crapez, E.; Castan, F.; Senellart, H.
errShare
errSave
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trial
err2025-04-23
err0
PREAI
errAziz Zaanan; Olivier Bouché; Christelle de la Fouchardière; Karine Le Malicot; Simon Pernot; Christophe Louvet; Pascal Artru; Valérie Le Brun Ly; Kais Aldabbagh; Faiza Khemissa-Akouz; Thierry Lecomte; Hélène Castanie; Margot Laly; Damien Botsen; Gael Roth; Emmanuelle Samalin; Marie Muller; Gilles Breysacher; Sylvain Manfredi; Jean-Marc Phelip; Julien Taieb
errShare
errSave
Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC
err2025-03-01
err0
errOAAI
errCuvelier, C.; Brahmi, M.; Sobhani, I.; Verret, B.; Grancher, A.; Penel, N.; Toulmonde, M.; Lahlou, W.; Dupuis, H.; Calavas, L.; Muller, M.; Watson, S.; Bruyat, D.; Poumeaud, F.; Chaigneau, L.; Manfredi, S.; Lecomte, T.; Bertucci, F.; Ghiringhelli, F.; Pracht, M.; Mourthadhoi, F.; Monceau-Baroux, L.; Helyon, M.; Kurtz, J. E.; Rogquin, G.; Regenet, N.; Vinches, M.; Tougeron, D.; Wolkenstein, P.; Blay, J. Y.; Bouche, O.; Hautefeuille, V.
errShare
errSave
Rectal cancer- French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, and GRECCAR)
err2025-03-01
err0
errOAAI
errCotte, Eddy; Arquilliere, Justine; Artru, Pascal; Bachet, Jean Baptiste; Benhaim, Leonor; Bibeau, Frederic; Christou, Niki; Conroy, Thierry; Doyen, Jerome; Hoeffel, Christine; Meillan, Nicolas; Mirabel, Xavier; Pioche, Mathieu; Del Campo, Eleonor Rivin; Vendrely, Veronique; Huguet, Florence; Bouche, Olivier
errShare
errSave
Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy
err2025-02-05
err0
errOAAI
errPerrier, Marine; Fontaine, Marine; Bertin, Eric; Carlier, Claire; Botsen, Damien; Djelouah, Manel; Francois, Eric; Guilbert, Philippe; Saint, Angelique; Slimano, Florian; Torielli, Paolo; Brugel, Mathias; Bouche, Olivier
errShare
errSave
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors
err2025-01-02
err0
errOAAI
errRandrian, Violaine; Portales, Fabienne; Bouche, Olivier; Thezenas, Simon; Chibaudel, Benoist; Mabro, May; Terrebonne, Eric; Garnier-Tixidre, Claire; Louvet, Christophe; Andre, Thierry; Aparicio, Thomas; Dubreuil, Olivier; Bouche, Gregoire; Ychou, Marc; Tougeron, David
errShare
errSave